What is the official website of PPD™ Laboratory Services ?

The official website of PPD™ Laboratory Services is https://www.ppd.com/our-solutions/ppd-laboratories/.

What is PPD™ Laboratory Services's cybersecurity risk score?

PPD™ Laboratory Services has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has PPD™ Laboratory Services experienced?

According to Rankiteo, PPD™ Laboratory Services currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has PPD™ Laboratory Services been affected by any supply chain cyber incidents ?

According to Rankiteo, PPD™ Laboratory Services has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does PPD™ Laboratory Services have SOC 2 Type 1 certification ?

According to Rankiteo, PPD™ Laboratory Services is not certified under SOC 2 Type 1.

Does PPD™ Laboratory Services have SOC 2 Type 2 certification ?

According to Rankiteo, PPD™ Laboratory Services does not hold a SOC 2 Type 2 certification.

Does PPD™ Laboratory Services comply with GDPR ?

According to Rankiteo, PPD™ Laboratory Services is not listed as GDPR compliant.

Does PPD™ Laboratory Services have PCI DSS certification ?

According to Rankiteo, PPD™ Laboratory Services does not currently maintain PCI DSS compliance.

Does PPD™ Laboratory Services comply with HIPAA ?

According to Rankiteo, PPD™ Laboratory Services is not compliant with HIPAA regulations.

Does PPD™ Laboratory Services have ISO 27001 certification ?

According to Rankiteo,PPD™ Laboratory Services is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does PPD™ Laboratory Services operate in ?

PPD™ Laboratory Services operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does PPD™ Laboratory Services have ?

PPD™ Laboratory Services employs approximately 2 people worldwide.

Does PPD™ Laboratory Services own any subsidiaries ?

PPD™ Laboratory Services presently has no subsidiaries across any sectors.

How many LinkedIn followers does PPD™ Laboratory Services have ?

PPD™ Laboratory Services's official LinkedIn profile has approximately 16,501 followers.

What is the NAICS classification code for PPD™ Laboratory Services ?

PPD™ Laboratory Services is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does PPD™ Laboratory Services have a Crunchbase profile ?

No, PPD™ Laboratory Services does not have a profile on Crunchbase.

Does PPD™ Laboratory Services have a LinkedIn profile ?

Yes, PPD™ Laboratory Services maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/ppd-laboratories.

How many cybersecurity incidents has PPD™ Laboratory Services experienced ?

As of June 6, 2026, Rankiteo reports that PPD™ Laboratory Services has experienced 1 cybersecurity incidents.

How many peer or competitor companies does PPD™ Laboratory Services have ?

PPD™ Laboratory Services has an estimated 5,673 peer or competitor companies worldwide.

What types of cybersecurity incidents has PPD™ Laboratory Services faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

PLS

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

PPD™ Laboratory Services Vendor Cyber Rating & Cyber Score

ppd.com

Add Your Compliance Badge

PPD™ Laboratory Services combines superior scientific expertise with industry-leading technologies supported by a commitment to exceptional quality. Our clients benefit from comprehensive lab services spanning bioanalytical, biomarkers, central lab, GMP and vaccine sciences. Our laboratory services accelerate pharmaceutical development for small molecules and biologics, allowing clients to make faster decisions about their compounds.

PLS A.I CyberSecurity Scoring

Scoring History

PLS

PPD™ Laboratory Services CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

PPD™ Laboratory Ser...

Breach

7/2017

THE206072925

Loading…

A.I.

PLS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for PLS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for PPD™ Laboratory Services in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for PPD™ Laboratory Services in 2026.

Incident Types PLS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for PPD™ Laboratory Services in 2026.

Incident History - PLS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

PPD™ Laboratory Services Subsidiaries

PLS

Pharmaceutical Manufacturing

Website: https://www.ppd.com/our-solutions/ppd-laboratories/

Company Size: 5,001-10,000 employees

Thermo Fisher ScientificBiotechnology Research

PatheonPharmaceutical Manufacturing

Gallus BioPharmaceuticalsBiotechnology Research

Laureate Biopharmaceutical ServicesBiotechnology Research

Laureate PharmaBiotechnology Research

Thermo ScientificBiotechnology Research

FEI CompanyNanotechnology Research

Accelerating MicroscopyBiotechnology

Chromatography & Mass SpectrometryBiotechnology

Fisher HealthcareHospitals and Health Care

Advancing MaterialsResearch Services

Thermo Fisher Spectral CytometryBiotechnology Research

Unity Lab ServicesBiotechnology Research

PPDResearch Services

Accelerated Enrollment SolutionsPharmaceutical Manufacturing

EvideraResearch Services

LiveTracker®Research Services

PPD™ Biotech SolutionsPharmaceutical Manufacturing

Loading…

PPD™ Laboratory Services Similar Companies

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Loading…

NEWS

PPD™ Laboratory Services CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

August 09, 2016 07:00 AM

Evidera to Join PPD, Creating the Global Leader in Real-World Research

Evidera will become a wholly owned subsidiary of PPD, delivering peri- and post-approval studies, health economics, outcomes research, epidemiology and market...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-7654

SUMMARY

The Admin Columns plugin for WordPress is vulnerable to PHP Object Injection leading to Remote Code Execution in versions up to and including 7.0.18. This is due to the use of `unserialize()` without an `allowed_classes` restriction in the `IdsToCollection::get_ids_from_string()` function, which processes attacker-controlled post meta values without proper validation. This makes it possible for authenticated attackers with Contributor-level access and above to inject a serialized PHP object into a post's custom meta field and trigger arbitrary code execution by exploiting a bundled POP gadget chain, resulting in remote code execution as the web server user.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-7523

SUMMARY

The Alba Board plugin for WordPress is vulnerable to authorization bypass in all versions up to, and including, 2.1.3. This is due to the plugin not properly verifying that a user is authorized to perform an action. This makes it possible for authenticated attackers, with subscriber-level access and above, to access arbitrary private alba_card post data, including title, description, assignee, due date, tags, and comments, that is intended to be restricted to Administrators and Editors. The handler is registered via the wp_ajax_nopriv_ hook and its nonce is exposed to all site visitors through wp_localize_script on pages containing the [alba_board] shortcode, making this exploitable by unauthenticated users who can access any such page.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-45409

SUMMARY

Internationalized Domain Names in Applications (IDNA) for Python provides support for Internationalized Domain Names in Applications (IDNA) and Unicode IDNA Compatibility Processing. In versions prior to 3.15, payloads such as `"\u0660" * N` or `"\u30fb" * N + "\u6f22"` utilize the `valid_contexto` function prior to length rejection, and for high values of `N` will take a long time to process. This is the same issue as CVE-2024-3651, however the original remediation in 2024 was not a complete fix. A specially crafted argument to the `idna.encode()` function could consume significant resources. This may lead to a denial-of-service. Starting in version 3.14, the function rejects long inputs as soon as practicable prior to any further processing to minimize resource consumption. In version 3.15, this approach was extended to lesser used alternate functions (i.e. per-label conversions and codec support). A workaround is available. Domain names cannot exceed 253 characters in length. If this length limit is enforced prior to passing the domain to the `idna.encode()` function, it should no longer consume significant resources. This is triggered by arbitrarily large inputs that would not occur in normal usage, but may be passed to the library assuming there is no preliminary input validation by the higher-level application.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/kjd/idna/security/advisories/GHSA-65pc-fj4g-8rjx

CVE-2026-11431

SUMMARY

A path traversal vulnerability exists in the Projects Service download endpoint shared by Altium Enterprise Server and Altium 365. An authenticated user can supply a crafted path parameter that bypasses validation, allowing arbitrary files (including entire directories returned as archives) to be read from the server filesystem. Because the readable files include service configuration and credential material, exploitation can be used to gather information enabling further compromise. The issue can be combined with CVE-2026-11424 to reach the cloud-side endpoint. On multi-tenant Altium 365 deployments, the readable configuration could have exposed credentials shared across services. Altium Enterprise Server is fixed in 8.1.1; the issue has been remediated in Altium 365 at the service level.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: )

cvss4

Base Score: 8.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://www.altium.com/platform/security-compliance/security-advisories

CVE-2026-11429

SUMMARY

A path traversal vulnerability exists in the Git Service component shared by Altium Enterprise Server and Altium 365. The service accepts a sequence of post-clone file-manipulation operations that use user-supplied paths without validation, allowing an authenticated user with basic git access to move arbitrary files outside the intended repository area. This file-move primitive can be used to place attacker-controlled script content into directories where it is later executed by the service, resulting in remote code execution under the Git Service account. On multi-tenant Altium 365 deployments, this could have allowed access to data belonging to other tenants on the same infrastructure node. Altium Enterprise Server is fixed in 8.1.1; the issue has been remediated in Altium 365 at the service level.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: )

cvss4

Base Score: 9.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://www.altium.com/platform/security-compliance/security-advisories

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…